LOSARTAN ZENTIVA LAB 100 mg, film-coated tablet scored 84 tablets
Active ingredients: Losartan, Losartan potassium
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet84 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOSARTAN ZENTIVA LAB 100 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 84 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Apr 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64892601CIP73021944CIP133400930219447Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LOSARTAN POTASSIQUEcomprimé | 100 mg · un comprimé | SA |
| LOSARTANcomprimé | 91,6 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.